Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats

References

• Vaziri ND, Wang XQ, Ni Z, Kivlighn S, Shahinfar S. Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR. Biochim Biophys Acta. 2002;1592(2):153–161
   PubMed Web of Science ®Google Scholar
• Pinho MJ, Serrao MP, Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2007;292(5):1452–1463
   Google Scholar
• Kim SW, Wang W, Kwon T-H, Knepper MA, Frokiaer J, Nielsen S. Increased expression of ENaC subunits and increased apical targeting of AQP2 in the kidneys of spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2005;289(5):957–968
   Google Scholar
• Welch WJ, Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int. 2001;59(4):1257–1263
   PubMedGoogle Scholar
• Kitiyakara C, Wilcox S. Antioxidants for hypertension. Curr Opin Nephrol Hypertens. 1998;7(5):531–538
   PubMed Web of Science ®Google Scholar
• Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension. 2006;48(3):467–472
   PubMedGoogle Scholar
• Galle J, Heinloth A, Schwedler S, Wanner C. Effect of HDL and atherogenic lipoproteins on formation of and renin release in juxtaglomerular cells. Kidney Int. 1997;51(1):253–260
   PubMedGoogle Scholar
• Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol. 2002;283(3):885–892
   Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension what is the clinical significance? Hypertension. 2004;44(3):248–252
   PubMed Web of Science ®Google Scholar
• Kopkan L, Castillo A, Navar LG, Majid DSA. Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol. 2006;290(1):80–86
   PubMed Web of Science ®Google Scholar
• Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008;60(4):418–469
   PubMed Web of Science ®Google Scholar
• Patel K, Chen Y, Dennehy K, et al. Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):37–43
   Google Scholar
• Welch WJ, Mendonca M, Blau J, et al. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int. 2005;68(1):179–187
   PubMedGoogle Scholar
• Kawada N, Dennehy K, Solis G, et al. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol. 2004;287(4):753–759
   Google Scholar
• Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J. 1982;206(2):267–277
   PubMed Web of Science ®Google Scholar
• Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci. 2008;29(2):84–90
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J. 2001;20(21):6008–6016
   PubMed Web of Science ®Google Scholar
• Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun. 2004;313(1):22–27
   PubMedGoogle Scholar
• Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine-lyase. Science. 2008;322(5901):587–590
   PubMed Web of Science ®Google Scholar
• Bos EM, Leuvenink HGD, Snijder PM, et al. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol. 2009;20(9):1901–1905
   PubMed Web of Science ®Google Scholar
• Xia M, Chen L, Muh RW, Li PL, Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther. 2009;329(3):1056–1062
   PubMed Web of Science ®Google Scholar
• Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol. 2005;288(1):22–28
   PubMed Web of Science ®Google Scholar
• Kopkan L, Majid DSA. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension. 2005;46(4):1026–1031
   PubMedGoogle Scholar
• Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KUS, Whitworth JA. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens. 2004;17(3):260–265
   PubMedGoogle Scholar
• Ahmad FD, Sattar MA, Rathore HA, et al. Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail. 2012;34(2):203–210
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316–328
   PubMed Web of Science ®Google Scholar
• Ali MY, Ping CY, Mok Y. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol. 2006;149(6):625–634
   PubMed Web of Science ®Google Scholar
• Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol. 2004;287(2):695–703
   Google Scholar
• Xu H, Fink GD, Galligan JJ. Tempol lowers blood pressure and sympathetic nerve activity but not vascular in DOCA-salt rats. Hypertension. 2004;43(2):329–334
   PubMedGoogle Scholar
• Just A, Olson AJM, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol. 2007;292(1):83–92
   Google Scholar
• Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 2004;13(1):93–99
   PubMed Web of Science ®Google Scholar
• Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2α. Hypertension. 1999;33(1):424–428
   PubMedGoogle Scholar
• Hong H-J, Hsiao G, Cheng T-H, Yen M-H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension. 2001;38(5):1044–1048
   PubMedGoogle Scholar
• Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med. 1996;20(3):443–448
   PubMedGoogle Scholar
• Chai W, Wang Y, Linm JY, et al. Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res. 2011;176:210–219
   PubMedGoogle Scholar
• Muzaffar S, Shukla N, Bond M, et al. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res. 2008;45(6):521–528
   PubMedGoogle Scholar
• Guzik TJ, West NEJ, Pillai R, Taggart DP, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39(6):1088–1094
   PubMed Web of Science ®Google Scholar
• Cowley Jr AW, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275(20):1581–1589
   PubMedGoogle Scholar
• Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension. 1982;4(6):908–915
   PubMedGoogle Scholar
• Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension. 1990;15(6 Pt 1):547–559
   PubMedGoogle Scholar
• Juncos R, Garvin JL. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. Am J Physiol Renal Physiol. 2005;288(5):982–987
   PubMed Web of Science ®Google Scholar
• Riazi S, Tiwari S, Sharma N, Rash A, Ecelbarger CM. Abundance of the Na-K-2Cl cotransporter NKCC2 is increased by high-fat feeding in Fischer 344 X Brown Norway (F1) rats. Am J Physiol Renal Physiol. 2009;296(4):762–770
   Google Scholar
• Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293(4):2009–2023
   Google Scholar
• Alexander WD, Branch RA, Levine DF, Hartog M. The urinary sodium: potassium ratio and response to diuretics in resistant oedema. Postgrad Med J. 1977;53(617):117–121
   PubMed Web of Science ®Google Scholar
• Bolterman RJ, Manriquez MC, Ruiz MCO, Juncos LA, Romero JC. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46(4):943–947
   PubMedGoogle Scholar
• Chabrashvili T, Kitiyakara C, Blau J, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol. 2003;285(1):117–124
   PubMed Web of Science ®Google Scholar
• Laggner H, Hermann M, Esterbauer H, et al. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens. 2007;25(10):2100–2104
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Fukui T, Fujisawa Y, et al. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension. 2001;37(1):77–83
   PubMed Web of Science ®Google Scholar